Ovid Therapeutics

$3.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-1.93%) Today

-$0.03 (-0.98%) As of 11:38 PM UTC after-hours

Why Robinhood?

You can buy or sell OVID and other stocks, options, and ETFs commission-free!

About OVID

Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY. The listed name for OVID is Ovid Therapeutics Inc. Common Stock.

CEO

Jeremy Max Levin

Employees

Headquarters

New York, New York

Founded

2014

Market Cap

224.54M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.89M

High Today

$3.25

Low Today

$3.04

Open Price

$3.12

Volume

1.19M

52 Week High

$9.40

52 Week Low

$1.80

Analyst Ratings

71%

of 7 ratings

Buy

71%

Hold

29%

Sell

OVID Earnings

-$0.43

-$0.29

-$0.14

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, After Hours